Ian R. Phillips

Ian R. Phillips's AcademicInfluence.com Rankings

Ian R. Phillips

Philosophy

#5365

World Rank

#8136

Historical Rank

Logic

#2653

World Rank

#3671

Historical Rank

philosophy Degrees

Ian R. Phillips

Biology

#7159

World Rank

#10033

Historical Rank

Microbiology

#349

World Rank

#397

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Ian R. Phillips's Degrees

PhD Microbiology University of California, Berkeley
Doctorate Medicine Stanford University

Why Is Ian R. Phillips Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ian R. Phillips's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cowan and Steel's Manual for the Identification of Medical Bacteria (1993) (1229)
Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. (2003) (1047)
The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. (2003) (806)
Hands as route of transmission for Klebsiella species. (1977) (482)
Induction of the SOS response by new 4-quinolones. (1987) (208)
Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. (1985) (196)
API ZYM: a simple rapid system for the detection of bacterial enzymes. (1977) (180)
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli (1995) (156)
Letter: Staphylococcal infection in the newborn. (1974) (150)
Bacteremia due to Escherichia coli: a study of 861 episodes. (1990) (147)
A hospital outbreak of antibiotic-resistant Acinetobacter anitratus: epidemiology and control. (1980) (135)
ANAEROBIC VAGINOSIS (NON-SPECIFIC VAGINITIS): CLINICAL, MICROBIOLOGICAL, AND THERAPEUTIC FINDINGS (1983) (134)
Outbreak of hospital infection caused by contaminated autoclaved fluids. (1972) (126)
Necrobacillosis: a forgotten disease. (1984) (120)
The application of flow cytometry to the study of bacterial responses to antibiotics. (1993) (119)
EPIDEMIC MULTIRESISTANT ESCHERICHIA COLI INFECTION IN WEST LAMBETH HEALTH DISTRICT (1988) (118)
Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria. (2004) (108)
Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit. (1971) (107)
Antibacterial Activity of Cefamandole, a New Cephalosporin Antibiotic, Compared with that of Cephaloridine, Cephalothin, and Cephalexin (1973) (103)
The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates. (2001) (98)
Acute bacterial infection in kwashiorkor and marasmus. (1968) (95)
GARDNERELLA VAGINALIS, ANAEROBES, AND VAGINAL DISCHARGE (1982) (94)
Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin (1990) (93)
The comparative in-vitro activity of eight newer quinolones and nalidixic acid. (1986) (91)
Antibacterial action of ciprofloxacin (1995) (90)
Food as a source of Klebsiella species for colonisation and infection of intensive care patients. (1978) (90)
The causative organisms of septicaemia and their epidemiology. (1990) (83)
The comparative in-vitro activity of pefloxacin. (1986) (77)
Staphylococcus aureus bacteraemia: 400 episodes in St Thomas's Hospital. (1984) (76)
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. (1984) (76)
Microbiology of pyogenic liver abscess. (1981) (73)
Identification of Pseudomonas aeruginosa in the clinical laboratory. (1969) (73)
Diversity of staphylococci exhibiting high-level resistance to mupirocin. (1990) (72)
In vitro antibacterial activity of norfloxacin (MK-0366) (1982) (72)
Antibacterial Activity of Cefuroxime, a New Cephalosporin Antibiotic, Compared with That of Cephaloridine, Cephalothin, and Cefamandole (1976) (70)
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics (1994) (68)
Infective complications associated with the use of the Quinton 'Permcath' for long-term central vascular access in haemodialysis. (1991) (68)
An outbreak of Serratia marcescens transmitted by contaminated breast pumps in a special care baby unit. (1986) (64)
Does the use of antibiotics in food animals pose a risk to human health? A reply to critics (2004) (63)
Anaerobic axillary abscess. (1979) (63)
Infective endocarditis, 1970-1979. A study of culture-positive cases in St. Thomas' Hospital. (1980) (62)
Mechanisms of resistance to aminoglycosides in clinical isolates. (1982) (61)
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases (1980) (61)
Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. (1986) (61)
Comparative in vitro activity of gemifloxacin. (2000) (60)
Ceftazidime: in-vitro antibacterial activity and susceptibility to β-lactamases compared with that of cefotaxime, moxalactam and other β-lactam antibiotics (1981) (60)
Epidemiological patterns of klebsiella colonization and infection in an intensive care ward (1978) (59)
Vancomycin for Staphylococcal Shunt Site Infections in Patients on Regular Haemodialysis (1970) (58)
Group B streptococci in the female genital tract. (1976) (57)
Laboratory diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis (1988) (57)
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. (1985) (56)
CEFTAZIDIME—A NEW EXTENDED-SPECTRUM CEPHALOSPORIN (1982) (52)
Importation of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom (1990) (49)
Aspects of the plasmid-mediated antibiotic resistance and epidemiology of Klebsiella species. (1981) (49)
Mechanisms of hyperproduction of TEM-1 beta-lactamase by clinical isolates of Escherichia coli. (1995) (46)
Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence. (1972) (46)
The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988. (1990) (44)
Antimicrobial misuse, antibiotic policies and information resources. (1980) (43)
The evaluation of a typing scheme for coagulase-negative staphylococci suitable for epidemiological studies. (1989) (43)
Haemophilus influenzae Meningitis in Adults (1974) (42)
The use of bacitracin as a growth promoter in animals produces no risk to human health. (1999) (41)
Induction of the SOS gene (umuC) by 4-quinolone antibacterial drugs. (1992) (41)
4-Quinolone-resistant Neisseria gonorrhoeae in the United Kingdom. (1991) (41)
The identification of pseudomonads and related bacteria in a clinical laboratory. (1978) (41)
The in-vitro activity of PD127,391, a new quinolone. (1988) (40)
Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom. (1989) (40)
Comparative activity of the 4-quinolones. (1988) (40)
Metronidazole and anaerobic sepsis. (1976) (39)
DNA sequence differences of ampD mutants of Citrobacter freundii (1995) (39)
Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. (1986) (39)
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. (2000) (39)
Bacterial mutagenicity and the 4-quinolones. (1987) (38)
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe. (1999) (37)
Reduced sensitivity to β-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infections (1983) (37)
The epidemiology of peritonitis caused by coagulase-negative staphylococci in continuous ambulatory peritoneal dialysis. (1989) (37)
The β-lactamases of Bacteroides species (1981) (37)
In-vitro Comparison of Erythromycin, Lincomycin, and Clindamycin (1970) (36)
3 – In vitro Properties of the Quinolones (1988) (36)
Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia. (1995) (36)
Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis. (1992) (35)
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. (2002) (35)
The impact of antibiotic policy on prescribing in a London teaching hospital. A one-day prevalence survey as an indicator of antibiotic use. (1983) (35)
Brucella melitensis endocarditis: successful treatment of an infected prosthetic mitral valve (1974) (35)
The antimicrobial susceptibility of anaerobic bacteria in a London teaching hospital. (1981) (35)
Lung abscess and empyema. (1985) (34)
The susceptibility to growth-promoting antibiotics of Enterococcus faecium isolates from pigs and chickens in Europe. (2005) (34)
Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). (1990) (34)
Various regimens of trimethoprim-sulfamethoxazole used in the treatment of gonorrhea. (1973) (34)
Diarrhoea in Kwashiorkor (1968) (34)
In-vitro activity of twelve antibacterial agents against Neisseria gonorrhoeae. (1970) (34)
Antibiotic susceptibilities of streptococci from the mouth and blood of patients treated with penicillin or lincomycin and clindamycin. (1976) (34)
The aetiology of perirectal sepsis (1982) (33)
Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases. (1983) (32)
Ciprofloxacin for treating urethral gonorrhoea in men. (1986) (32)
The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom. (1987) (32)
Staphylococcal bacteraemia, fusidic acid, and jaundice. (1980) (32)
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15. (1990) (32)
The ability of β-lactam antibioties to select mutants with derepressed β-lactamase synthesis from Citrobacter freundii (1995) (31)
The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae. (1976) (30)
Rifampicin in experimental Mycobacterium ulcerans infection. (1972) (30)
Activity of Sulfamethoxazole and Trimethoprim Against Bacteroides fragilis (1976) (30)
In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases (1980) (29)
Spectinomycin resistant gonococci. (1983) (29)
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. (1981) (29)
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents. (1993) (29)
Relative Instability of Cephaloridine to Staphylococcal Penicillinase (1965) (28)
Prosthetic valve endocarditis. (1983) (27)
Clinical index to predict bacteraemia caused by staphylococci (1993) (27)
A taxonomic study of clinical isolates of Pseudomonas pickettii, 'P. thomasii' and 'group IVd' bacteria. (1979) (27)
The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. (1992) (26)
Anaerobic bacteremia: declining rate over a 15-year period. (1991) (26)
A physiological classification of viridans streptococci by use of the API-20STREP system. (1989) (26)
Evaluation of the Rapid ID 32A system for identification of anaerobic Gram-negative bacilli, excluding the Bacteroides fragilis group. (1999) (26)
beta-Lactamase detection by three simple methods: Intralactam, nitrocefin and acidimetric. (1980) (26)
Comparative In-Vitro Properties of the Quinolones (2000) (26)
A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men. (1996) (25)
Mupirocin resistance in coagulase-negative staphylococci. (1993) (25)
Report of the Comité de l'Antibiogramme. (1997) (24)
Antibiotic use in animals. (2004) (24)
Imported penicillinase producing Neisseria gonorrhoeae becomes endemic in London. (1983) (24)
Serological grouping of streptococci by a slide coagglutination method. (1977) (24)
ANAEROBIC CURVED RODS IN VAGINITIS (1982) (24)
Pyrolysis gas chromatography of Pseudomonas and Acinetobacter species. (1980) (24)
Clinical uses and control of rifampicin and clindamycin. (1971) (23)
Transferable mupirocin-resistance. (1988) (23)
Detection of ciprofloxacin resistance in gram-negative bacteria due to alterations in gyrA. (1992) (23)
Antibiotic sensitivity of theBacteroides fragilis group in Europe (1992) (23)
Septicaemia in the newborn and elderly. (1994) (23)
A comparison of four culture methods for diagnosing infection in continuous ambulatory peritoneal dialysis. (1990) (23)
Metronidazole in surgical infections. (1978) (23)
Active intervention dramatically reduces CAPD-associated infection. (1991) (22)
Vancomycin therapy failure in Listeria monocytogenes peritonitis in a patient on continuous ambulatory peritoneal dialysis. (1991) (22)
Towards a common susceptibility testing method? (2000) (22)
Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres. (1991) (22)
Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases. (1982) (21)
Prudent use of antibiotics: are our expectations justified? (2001) (21)
Evaluation of methods for typing coagulase-negative staphylococci. (1992) (21)
Mycobacterium tuberculosis as a cause of peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. (1986) (21)
Prosthetic valve endocarditis. (1983) (20)
Ingrowing toenails: an evaluation of two treatments. (1981) (20)
Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli. (1986) (20)
Determination of antibiotic sensitivities by the Sensititre system. (1978) (20)
Aminoglycoside resistance among Enterobacteriaceae and Acinetobacter species. (1978) (20)
RAPD typing of clinical isolates of Staphylococcus haemolyticus (1994) (20)
The identification of Gardnerella vaginalis. (1983) (19)
Prevalence and Mechanisms of Aminoglycoside Resistance (1988) (19)
The effects on ß-lactam susceptibility of phenotypic induction and genotypic derepression of ß-lactamase synthesis (1986) (18)
The 1997 Garrod Lecture. The subtleties of antibiotic resistance. (1998) (17)
Adherence characteristics of coagulase-negative staphylococci isolated from patients with infective endocarditis. (1995) (17)
Importance of beta-lactamase induction (2006) (17)
Vaginal manipulation and anaerobic breast abscesses. (1981) (17)
Diagnosis of gonorrhoea in women. (1976) (17)
The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin. (1980) (17)
Sensitivity of Citrobacter freundii and Citrobacter koseri to cephalosporins and penicillins (1974) (16)
Isoelectric focusing of Bacteroides melaninogenicus group beta-lactamases (1981) (16)
Antibiotic sensitivity of gonococci and treatment of gonorrhoea in Uganda. (1970) (16)
The mechanisms of resistance to aminoglycosides in the genus Pseudomonas. (1978) (16)
Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group. (1992) (16)
Past and current use of clindamycin and lincomycin. (1981) (16)
Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men. (1996) (15)
Assessment of transport and isolation methods for gonococci. (1980) (15)
Antibacterial Activity of Netilmicin, a New Aminoglycoside Antibiotic, Compared with That of Gentamicin (1977) (15)
Resistance as a cause of treatment failure. (1986) (15)
Carbon dioxide-dependent Escherichia coli. (1978) (15)
Staphylococcus aureus bacteraemia (1984) (15)
Susceptibility of Bacteroides fragilis to trimethoprim and sulphamethoxazole. (1974) (14)
The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid. (1986) (14)
Infective Endocarditis, 1970–1979 (1980) (14)
Susceptibility of Bacteroides fragilis to spectinomycin. (1975) (13)
Antibiotic clinical trials—the Witley Park Symposium (1999) (13)
In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria (1993) (13)
The computerized documentation of septicaemia. (1990) (12)
The preservation of micro‐organisms in biological specimens stored at – 70°C (1989) (12)
Carriage of gentamicin-resistant coagulase-negative staphylococci in patients on continuous ambulatory peritoneal dialysis. (1987) (12)
Prevalence of resistance to beta-lactam antibiotics in Escherichia coli isolated from blood from 1969-1991. (1992) (12)
Aminoglycoside 6'-N acetyltransferase production by an isolate of Pseudomonas maltophilia. (1978) (12)
European multicentre evaluation of a commercial system for identification of methicillin-resistantStaphylococcus aureus (1996) (12)
Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis. (1973) (12)
Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. (1981) (12)
The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis. (1989) (12)
New Antibacterial Strategies. (1991) (11)
Comparison of radiometric and gas capture system for blood cultures. (1986) (11)
The disinfection of clinically contaminated Matburn suction pumps and baby incubators in an 'Aseptor' formalin cabinet. (1980) (11)
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment. (1996) (11)
In-vitro antigonococcal activity of rosoxacin (WIN 35213). (1981) (11)
Assessment of a selective medium for the isolation of Neisseria gonorrhoeae. (1979) (11)
European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes. (1988) (10)
A qualitative and quantitative study of the cellular fatty acids of 'Streptococcus milleri' with capillary gas chromatography. (1989) (10)
Reproducible pyrolysis-gas chromatography of micro-organisms with solid stationary phases and isothermal oven temperatures. (1981) (10)
A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens. (1996) (10)
Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins (1990) (10)
Chlorhexidine hypersensitivity of ciprofloxacin-resistant variants of Pseudomonas aeruginosa PAO. (1993) (10)
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases. (1981) (10)
Importance of organisms producing broad-spectrum SHV-group beta-lactamases into the United Kingdom. (1990) (10)
Predictive index for optimizing empiric treatment of gram-negative bacteremia. (1991) (10)
Lessons from the past: a personal view. (1998) (10)
Reevaluation of antibiotic breakpoints. (2001) (10)
Temocillin (BRL 17421): in-vitro antibacterial activity and susceptibility to beta-lactamases. (1982) (10)
β-Lactamases and susceptibility to β-lactam antibiotics in Escherickia coil (1992) (10)
The susceptibility of Neisseria gonorrhoeae to cefoxitin sodium. (1978) (9)
The in-vitro activity of temafloxacin compared with other antimicrobial agents. (1991) (9)
The aetiology of scrotal sepsis (1982) (9)
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin. (1991) (9)
Aminoglycoside resistance. (1984) (9)
The differentiation of asaccharolytic anaerobic gram-positive cocci by protein electrophoresis. (1991) (9)
The Comparative In Vitro Activity of FK-037 (Cefoselis), a New Broad-Spectrum Cephalosporin. (1995) (8)
Metronidazole in treatment of non-specific vaginitis. Clinical and microbiological findings in ten patients given 2 grams of metronidazole. (1983) (8)
Pseudomonads and related bacteria (1985) (8)
Differentiation of Streptococcus sanguis and S. mitior by whole-cell rhamnose content and possession of arginine dihydrolase. (1986) (8)
Incidence and Mechanisms of Resistance to the Combination of Amoxicillin and Clavulanic Acid in Escherichia coli (1998) (8)
Penicillinase producing Neisseria gonorrhoeae from St Thomas' Hospital 1976-1990--the first fifteen years. (1993) (8)
The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis. (1986) (8)
Standardization of susceptibility testing methods. (1997) (8)
Prevention of peritonitis in continuous ambulatory peritoneal dialysis (1990) (7)
The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae. (1978) (7)
Strategies for typing and properties of epidemic methicillin-resistantStaphylococcus aureus (1986) (7)
Short course ciprofloxacin therapy for CAPD peritonitis. (1990) (7)
Antibiotic clinical trials revisited. (2000) (7)
The emergence of resistance and the therapy of septicaemia. (1985) (7)
Occurrence of FIme plasmids in multiply antimicrobial-resistant Escherichia coli isolated from urinary tract infection (1993) (7)
Erythromycin-resistant Campylobacter jejuni (1984) (7)
Identification of viridans streptococci by pyrolysis-gas chromatography. (1989) (7)
The in vitro activity of 15 penicillins and mecillinam against Neisseria gonorrhoeae. (1977) (6)
Mechanisms of gentamicin resistance in gram-negative bacilli in Riyadh, Kingdom of Saudi Arabia. (1989) (6)
Two regimens of sultamicillin in treating uncomplicated gonorrhoea. (1985) (6)
Low dose intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). (1991) (6)
Infection with non-sporing anaerobic bacteria. A symposium of the British Society for Antimicrobial Chemotherapy held at the Royal College of Physicians, London. (1974) (6)
The rapid laboratory diagnosis of anaerobic infection (2005) (6)
Anaerobic paronychia (1981) (6)
Comparative activity of quinupristin/dalfopristin and RPR 106972 and the effect of medium on in-vitro test results. (1998) (6)
Housewife peritonitis: conjugal transfer of a pathogen. (1991) (6)
The in vitro antibacterial activity of nine aminoglycosides and spectinomycin on clinical isolates of common Gram-negative bacteria. (1977) (6)
The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-β-lactam antibiotic (1980) (6)
The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin. (1987) (5)
Introduction: Hospital infection into the 1990s (1988) (5)
Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases. (1985) (5)
In-vitro activity of purpuromycin and MDL 63,604 against microorganisms that cause vaginitis and vaginosis. (1995) (5)
In vitro activity of cefpodoxime, a new oral cephalosporin, compared with that of nine other antimicrobial agents (1991) (5)
The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii. (1995) (5)
European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin. (1994) (5)
Reduced sensitivity to beta-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infections. (1983) (5)
In-vitro antibacterial activity of cefoperazone, a piperazine cephalosporin. (1981) (5)
The therapeutic use of antibiotics in hospital practice : proceedings of a symposium held at St. Thomas's Hospital Medical School (1966) (5)
Use of 'Signal system' (Oxoid) for diagnosing infection in continuous ambulatory peritoneal dialysis (CAPD) (1987) (5)
The Taxonomy of the Asaccharolytic Anaerobic Gram-Positive COCCI (1987) (4)
Comparative in vitro Activity of Fosfomycin Trometamol against Urinary Tract Pathogens (1988) (4)
Comparison of antisera in the fluorescent antibody test for detection of Bacteroides spp in clinical specimens. (1982) (4)
Evaluation of the Rapid ID 32A system for the identification of the Bacteroides fragilis group. (1996) (4)
Two curved rods in non-specific vaginitis. (1984) (4)
Cefotetan: a new cephamycin. (1983) (4)
Class I beta-lactamases. Induction and derepression. (1989) (4)
Azthreonam, a synthetic monobactam. Based on symposium held at the XII International Congress of Chemotherapy, Florence, 23 July 1981. (1981) (4)
Meeting the challenges in clinical microbiology and infectious diseases. Proceedings of a workshop. April 1999, Birmingham, United Kingdom. (2000) (4)
The use of aminoglycoside 2'-N-acetyltransferase for the assay of gentamicin in serum, plasma and urine. (1977) (4)
A clinical, microbiological and toxicological assessment of clindamycin phosphate. (1975) (4)
Contamination of sterile fluids. (1978) (4)
Contaminated drip fluids. (1972) (4)
A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents. (1991) (4)
Treatment of gonorrhoea with three different antibiotic regimes: doxycycline 300 mg., procaine penicillin plus benzyl penicillin 2.4 m.u., benzyl penicillin 5 m.u. plus probenecid. (1970) (4)
Interference with gentamicin assays by gallium-67. (1980) (3)
SERRATIA MARCESCENS IN HOSPITAL PRACTICE (1977) (3)
Cefotaxime in the treatment of gonorrhoea caused by β-Mactamase-producing Neisseria gonorrhoeae (1984) (3)
ESGAB breakpoint determination: Clarithromycin (1991) (3)
The beta-lactamases of Bacteroides species. (1981) (3)
Ciprofloxacin and CAPD peritonitis. (1991) (3)
beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli. (1992) (3)
New methods for identification of obligate anaerobes. (1990) (3)
Standardization of Iso-Sensitest agar. (1993) (3)
Ecology of Infectious Diseases in Natural Populations, edited by B. T. Grenfell and A. P. Dobson, 1995 University Press, Cambridge (1998) (3)
The preservation of micro-organisms in biological specimens stored at-70 degrees C. (1989) (3)
Susceptibility testing of Klebsiella spp.--an international collaborative study in quality assessment. (1998) (3)
Role of Cephalosporins in Gonorrhoea and Other Sexually Transmitted Diseases (2012) (2)
Antibiotic sensitivity of anaerobic bacteria. (1979) (2)
Acheson: a missed opportunity for the new public health (1988) (2)
Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study. (1995) (2)
Anaerobic infections: the role of tinidazole. Proceedings of a symposium held in Edinburgh, Scotland, 19-20 April 1982. (1982) (2)
Disseminated histoplasmosis successfully treated with amphotericin B (1974) (2)
Advances in antibiotics. (1969) (2)
The use of an anaerobic incubator for the isolation of anaerobes from clinical samples. (1982) (2)
Reports of the european study group on antibiotic breakpoints (1991) (2)
Plasmid-mediated ceftazidime resistance. (1989) (2)
Breakpoint determination: Sparfloxacin (1994) (1)
Jacques F. Acar (1931–2020) (2020) (1)
The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic. (1980) (1)
Gentamicin assay in the presence of chloramphenicol. (1977) (1)
Cefotaxime in the treatment of gonorrhoea caused by beta-lactamase-producing Neisseria gonorrhoeae. (1984) (1)
Serological response to coagulase-negative staphylococci in patients with peritonitis on continuous ambulatory peritoneal dialysis (1993) (1)
Antibiotic sensitivity testing of anaerobes. (1982) (1)
Microbiology for clinicians: By R. N. GRUNEBERG. 1981. MTP Press Ltd., Lancaster. Pp. 179. 11.95 (1982) (1)
26 – Miscellaneous Anaerobic Infections (1989) (1)
Class I β-Lactamases (1989) (1)
Clinical Implications of Acquired Antimicrobial Resistance (1982) (1)
ESGAB breakpoint determination: Temafloxacin (1991) (0)
IDENTIFICATION OF PSEUDOMONAS AER UCINOSA IN THE CLINICAL LABORATORY (1969) (0)
Antibiotics and antimicrobial action: By S. M. HAMMONaDnd P. A. LAMBERT1. 978. London: Edward Arnold (Publishers) Ltd. Pp. 63. E3.20 hard back; El50 paper back. (1978) (0)
Neisseria gonorrhoeae . medium for the isolation of Assessment of a selective (0)
Significance of medical microbiology in the care of patients: Edited by Victor Lorian. 1982. 2nd ed. Williams & Wilkins, Baltimore and London. Pp. xiv and 474. £43.50. (1983) (0)
European Study Group on Antibiotic Breakpoints. Breakpoint determination: cefepime. (1994) (0)
Turnround times in a microbiology laboratory. (1991) (0)
The β-lactamases of Bacteroides fragilis (1982) (0)
Letter: Pyogenic liver abscess. (1976) (0)
MCQ tutor for students of microbiology: By John Gordon. 1978. W. Heinemann Medical Books Ltd, London. Pp. x and 256. £4.50 (1981) (0)
The Shorter Bergey's Manual of Determinative Bacteriology: Edited by J. G. HOLT. 1977. 8th ed. Baltimore: Williams and Wilkins. Pp. xv and 365; 19 plates. US$15.95. (1978) (0)
Penicillinase-producing Neisseria gonorrhoeae. (1982) (0)
GROUP B STREPTOCOCCI IN THE FEMALE GENITAL TRACT (1977) (0)
AAC(2') versus AAC(6') (1977) (0)
Ciprofloxacin-resistant methicillin-sensitive Staphylococcus aureus. (1991) (0)
Applied medical microbiology: By J. G. COLLEE. 1976. Oxford, London, Edinburgh, Melbourne: Blackwell Scientific Publications. Pp. 121. £2.80. (1977) (0)
Metronidazole and anaerobic sepsis. (1977) (0)
Staphylococcal infection of open granulating wounds (1987) (0)
Applied medical microbiology: By J. G. COLLEE. 1981. 2nd ed. Blackwell Scientific Publications, Oxford. Pp. 150. 5.50. (1982) (0)
Problems with enterococci. (1995) (0)
OFLOXACIN AS THE STANDARD 4-QUINOLONE IN SENSITIVITY TEST. AUTHOR'S REPLIES (1992) (0)
Antibiotic clinical trials—the Witley Park Symposium Summary (2000) (0)
Anaerobes in Clinical Microbiology (2013) (0)
Letter: Sensitivity of haemophilus influenzae to cephalosporins. (1974) (0)
Gentamicin in sexually transmitted disease. (1974) (0)
Notes of Orchids from Andalucía. II (2001) (0)
The laboratory and the management of anaerobic infection. (1982) (0)
Comparison ofantisera inthefluorescent antibody test fordetection ofBacteroides sppinclinical specimens (1982) (0)
PYOGENIC LIVER ABSCESS (1976) (0)
Quinolones and Induction of umuC and Mutagenicity (1993) (0)
Antibiotic resistance : Lessons for the future. Discussion (1998) (0)
Pre-ulcerative buruli lesions. (1970) (0)
Penicillinase-producing Neisseria gonorrhoeas. (1982) (0)
Consequences of increasing resistance to antimicrobial agents. Discussion (1998) (0)
Septic shock. (1970) (0)
Metronidazole in Anaerobic Infections: A Review of its Activity, Pharmacokinetics and Therapeutic Use (1978) (0)
Comparative efficacy and safety of single oral doses of sparfloxacin versos ciprofloxacin in the treatment of acote gonococcal orethritis in men (2005) (0)
Efficacy and Safety of Single Oral Dose Sparfloxacin vs Ciprofloxacin in Acute Gonococcal Urethritis in Males (1995) (0)
An assessment of the Microcult-GC culture test. (1979) (0)
Common bacterial infections in infancy and childhood: Edited by M. I. MARKS. 1979. Lancaster: MTP Press Ltd. Pp. xv and 140. £6.95. (1980) (0)
MIC Audit of Routine Ciprofloxacin Sensitivity Testing (1993) (0)
Proceedings: Antibiotic susceptibility of Streptococci isolated from blood. (1975) (0)
Roundtable discussion: Cephalosporins in the 1990s and beyond (2000) (0)
Reporting in-vitro activity of new antimicrobial agents. (1995) (0)
Breakpoint determination: Cefepime (1994) (0)
Disseminated histoplasmosis successfully treated with amphotericin (0)
Genes and spectrum : The theoretical limits. Discussion (1998) (0)
Tracing sources of infection associated with parenteral infusions (1978) (0)
A comparison of the homogeneous enzyme immunoassay (EMIT) autocarousel and quantitative single test (QST) systems with the radioenzymatic assay. (1986) (0)
Plasmid-mediated caftazidime resistance (1989) (0)
Anassessment oftheMicrocult-GC culture test (1979) (0)
Resistance in anaerobic bacteria. Based on a symposium held at the 12th International Congress of Chemotherapy Florence, 22 July 1981. (1981) (0)
The beta-lactamases of Bacteroides fragilis. (1982) (0)

This paper list is powered by the following services:

Ian R. Phillips's Academic­Influence.com Rankings

Ian R. Phillips's Degrees

Why Is Ian R. Phillips Influential?

Ian R. Phillips's Published Works

Published Works

Ian R. Phillips's AcademicInfluence.com Rankings